These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23642492)

  • 1. Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study).
    Borggraefe I; Bonfert M; Bast T; Neubauer BA; Schotten KJ; Maßmann K; Noachtar S; Tuxhorn I; May TW; Heinen F;
    Eur J Paediatr Neurol; 2013 Sep; 17(5):507-14. PubMed ID: 23642492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group.
    Rating D; Wolf C; Bast T
    Epilepsia; 2000 Oct; 41(10):1284-8. PubMed ID: 11051123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
    Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
    Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
    Coppola G; Franzoni E; Verrotti A; Garone C; Sarajlija J; Operto FF; Pascotto A
    Brain Dev; 2007 Jun; 29(5):281-4. PubMed ID: 17055681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
    Lee GH; Kim BM; Kang JK; Lee SA
    Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS).
    Xiao F; An D; Deng H; Chen S; Ren J; Zhou D
    Seizure; 2014 Oct; 23(9):756-61. PubMed ID: 24998415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial.
    Tacke M; Borggraefe I; Gerstl L; Heinen F; Vill K; Bonfert M; Bast T; ; Neubauer BA; Baumeister F; Baethmann M; Bentele K; Blank C; Blank HM; Bode H; Bosch F; Brandl U; Brockmann K; Dahlem P; Ernst JP; Feldmann E; Fiedler A; Gerigk M; Heß S; Hikel C; Hoffmann HG; Kieslich M; Klepper J; Kluger G; Koch H; Koch W; Korinthenberg R; Krois I; Kühne H; Kurlemann G; Mandl M; Mause U; Navratil P; Opp J; Penzien J; Prietsch V; Quattländer A; Rating D; Schara U; Shamdeen MG; Sprinz A; Wendker-Magrabi H; Stephani U; Muhle H; Straßburg HM; Töpke B; Trollmann R; Tuschen-Hofstätter E; Waltz S; Weber G; Wien FU; Wolff M; Polster T; Freitag H; Sönmez Ö; Reinhardt K; Traus M; Hoovey Z
    Seizure; 2018 Mar; 56():115-120. PubMed ID: 29475094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types.
    Fang Y; Wu X; Xu L; Tang X; Wang J; Zhu G; Hong Z
    J Clin Neurosci; 2014 Jan; 21(1):55-62. PubMed ID: 24231559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes.
    Kramer U; Shahar E; Zelnik N; Lerman-Sagie T; Watemberg N; Nevo Y; Ben-Zeev B
    J Child Neurol; 2002 Dec; 17(12):914-6. PubMed ID: 12593467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anticonvulsive treatment on neuropsychological performance in children with BECTS.
    Tacke M; Gerstl L; Heinen F; Heukaeufer I; Bonfert M; Bast T; Cornell S; Neubauer BA; Borggraefe I;
    Eur J Paediatr Neurol; 2016 Nov; 20(6):874-879. PubMed ID: 27553576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.
    Verrotti A; Coppola G; Manco R; Ciambra G; Iannetti P; Grosso S; Balestri P; Franzoni E; Chiarelli F
    Seizure; 2007 Apr; 16(3):271-5. PubMed ID: 17204435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy.
    Kanemura H; Sano F; Tando T; Sugita K; Aihara M
    Brain Dev; 2013 May; 35(5):386-91. PubMed ID: 22871391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
    Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
    Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
    Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
    Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.